RightFit Trial Directory

Leukemia clinical trials in Columbus, OH

38 recruiting leukemia studies with a site in Columbus, OH.

All trials in Columbus, OH · All Leukemia trials

RecruitingPhase 3NCT03150693

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Sponsor: Alliance for Clinical Trials in Oncology

Cincinnati, OH · Cleveland, OH · +452 more sites

RecruitingPhase 1NCT06846606

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

Sponsor: Auron Therapeutics, Inc.

Columbus, OH · +8 more sites

RecruitingPhase 1NCT04301076

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

Sponsor: National Cancer Institute (NCI)

Columbus, OH · +18 more sites

RecruitingPhase 2NCT06317649

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Sponsor: National Cancer Institute (NCI)

Cleveland, OH · Columbus, OH · +223 more sites

RecruitingPhase 3NCT07007312

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Sponsor: Kura Oncology, Inc.

Columbus, OH · +43 more sites

RecruitingPhase 1 / Phase 2NCT04065399

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Sponsor: Syndax Pharmaceuticals

Cincinnati, OH · Columbus, OH · +20 more sites

RecruitingPhase 1NCT05091424

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Sponsor: Hoffmann-La Roche

Columbus, OH · +4 more sites

RecruitingPhase 1NCT06440135

Ziftomenib Maintenance Post Allo-HCT

Sponsor: Massachusetts General Hospital

Columbus, OH · +1 more sites

RecruitingPhase 2NCT07061951

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Sponsor: National Cancer Institute (NCI)

Columbus, OH · +8 more sites

RecruitingPhase 2NCT06707493

Ivosidenib as Post-HSCT Maintenance for AML

Sponsor: Massachusetts General Hospital

Columbus, OH · +6 more sites

RecruitingPhase 2NCT05592015

Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia

Sponsor: Jonathan Brammer

Columbus, OH · +2 more sites

RecruitingPhase 3NCT07582432

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Sponsor: Grifols Biologicals, LLC

Columbus, OH · +4 more sites

RecruitingPhase 1NCT03802695

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Sponsor: Orca Biosystems, Inc.

Columbus, OH · +11 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Akron, OH · Cincinnati, OH · Cleveland, OH · +183 more sites

RecruitingPhase 2NCT07221500

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Sponsor: Nurix Therapeutics, Inc.

Cincinnati, OH · Cleveland, OH · Columbus, OH · +24 more sites

RecruitingPhase 1NCT04972942

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

Sponsor: New York Medical College

Columbus, OH · +15 more sites

RecruitingPhase 1 / Phase 2NCT03104491

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Sponsor: Leland Metheny

Cleveland, OH · Columbus, OH · +4 more sites

RecruitingPhase 1 / Phase 2NCT04049539

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH · +1 more sites

RecruitingPhase 2 / Phase 3NCT03013998

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

Sponsor: Beat AML, LLC

Cincinnati, OH · Columbus, OH · +29 more sites

RecruitingPhase 2NCT07734038

Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Sponsor: Kerry Rogers

Columbus, OH

RecruitingPhase 1 / Phase 2NCT06523556

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

Sponsor: Uma Borate

Columbus, OH

RecruitingPhase 2NCT06930352

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

Sponsor: Uma Borate

Columbus, OH

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Akron, OH · Cincinnati, OH · Cleveland, OH · +161 more sites

RecruitingPhase not listedNCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

Sponsor: Children's Oncology Group

Akron, OH · Cleveland, OH · +69 more sites

RecruitingPhase not listedNCT02560883

Hairy Cell Leukemia Patient Data Registry

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH · +4 more sites

RecruitingPhase 1NCT05418088

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Sponsor: Sumithira Vasu

Columbus, OH

RecruitingPhase not listedNCT05978141

A Registry for People With T-cell Lymphoma

Sponsor: Memorial Sloan Kettering Cancer Center

Columbus, OH · +25 more sites

RecruitingPhase 1NCT04771572

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Sponsor: Newave Pharmaceutical Inc

Cincinnati, OH · Columbus, OH · +5 more sites

RecruitingPhase 1 / Phase 2NCT04988555

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Sponsor: Sumitomo Pharma America, Inc.

Columbus, OH · +32 more sites

RecruitingPhase 4NCT06876649

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Sponsor: Eli Lilly and Company

Columbus, OH · +19 more sites

RecruitingPhase 2NCT05336812

Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia

Sponsor: Ohio State University Comprehensive Cancer Center

Columbus, OH

RecruitingPhase 2NCT06466122

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Sponsor: Kerry Rogers

Columbus, OH

RecruitingPhase 1NCT04848064

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Sponsor: John Reneau

Columbus, OH

RecruitingPhase 1NCT06366789

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

Sponsor: Lomond Therapeutics Holdings, Inc.

Cincinnati, OH · Columbus, OH · +10 more sites

RecruitingPhase 1NCT05780034

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Sponsor: Accutar Biotechnology Inc

Cleveland, OH · Columbus, OH · +7 more sites

RecruitingPhase 1NCT06501196

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Sponsor: BlossomHill Therapeutics

Columbus, OH · +12 more sites

RecruitingPhase not listedNCT07145411

HPC Offered for PRESERVE Expansion

Sponsor: Ossium Health, Inc.

Columbus, OH · +3 more sites

RecruitingPhase 1 / Phase 2NCT05503134

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

Sponsor: Nationwide Children's Hospital

Columbus, OH

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.